London Cancer begins a new future with UCLH on 1 September 2016

London Cancer is an integrated cancer system that supports lasting improvements in cancer prevention, diagnosis and care for people living in north east and north central London and west Essex. From 1 September 2016, London Cancer will be co-ordinated by University College London Hospitals NHS Foundation Trust (UCLH) as the new system leader for cancer care in the region.

London Cancer now forms a key pillar in the UCLH Cancer Collaborative, which itself is one of the three partners in the National Cancer Vanguard, along with Greater Manchester Cancer and RM Partners. The UCLH Cancer Collaborative will drive forward a vision where patients are diagnosed faster and more efficiently, have a better chance of survival, have a better experience of care and are better informed and supported.

London Cancer brings the experience and success achieved by the partnership since it was established in 2012 to the UCLH Cancer Collaborative and will continue to drive improvements in patient outcomes and experience across the region. The work undertaken by the London Cancer Pathway Boards and Expert Reference Groups will remain as essential as ever within the remit of the Vanguard, to drive delivery of new models of care and whole pathway improvements. The work of the boards, supported by the Centre for Cancer Outcomes, will continue to drive the use of best evidence-based practice, from prevention through to living with and beyond cancer or end of life care.

Updates about London Cancer’s work and progress will be shared in the usual ways and involvement by professionals and patients continues to be vital to the progress across the system.

London Cancer will continue to work with UCLPartners, its host since 2012, through programmes of work to improve the health and care of patients and the population.

For further information, visit the website at www.londoncancer.org